Preeclampsia Foundation Receives Action for Women's Health Award Recognition

Preeclampsia Foundation Awarded for Advancing Women's Health

The Preeclampsia Foundation, a notable non-profit organization based in the United States, has recently been acknowledged as one of the esteemed recipients of the Action for Women’s Health Award. This honor is part of an extensive initiative that has allocated $250 million to various organizations dedicated to enhancing mental and physical health for women globally. With over 4,000 participants from 119 nations competing for this funding, the recognition of the Preeclampsia Foundation highlights the vital role it plays in the realm of maternal health.

Established in 2000, the Preeclampsia Foundation is focused on improving health outcomes related to hypertensive disorders in pregnancy, particularly preeclampsia, which affects approximately 5-8% of pregnancies worldwide. These disorders not only pose serious threats to maternal health but also contribute significantly to infant mortality. The foundation’s commitment to education, advocacy, and research has positioned it as a leader in this niche yet critical area of women’s healthcare.

Robyn D'Oria, Chair of the Board of Directors of the Preeclampsia Foundation, expressed her gratitude for the recognition, stating that it underscores the progress made over the past 25 years in preventing preventable maternal and infant morbidity and mortality. D'Oria pointed out that despite the advancements, significant challenges remain, especially the need for better solutions for women diagnosed with preeclampsia other than the option of early delivery, which poses its own set of complications.

The funding awarded through the Action for Women’s Health initiative aims to bridge the gap in research and healthcare improvements that plague women’s health, particularly in underfunded areas. Historically, women’s health research has faced chronic under-investment, leaving many critical issues unresolved, including the need for better screening, prevention, management, and postnatal care for conditions like preeclampsia.

D’Oria highlighted that in order to enhance outcomes for women, research gaps must continue to be filled with adequate funding and resources. The foundation, alongside other similar organizations, is now primed to use these funds to further their research and development initiatives aimed at innovating care practices for pregnant women.

The Action for Women’s Health initiative, funded by Pivotal—a group founded by Melinda French Gates—aims to support organizations addressing the unique health challenges faced by women worldwide. Lever for Change, which has a successful track record of spotting impactful ideas, oversees this substantial funding initiative.

As societal insights and trends evolve, it is essential that organizations like the Preeclampsia Foundation receive support not just in financial terms but also through awareness and advocacy efforts. This recent accolade speaks not only to the foundation's achievements thus far but also to the critical work that lies ahead.

For more information on the Action for Women’s Health initiative and its awarded organizations, please visit Lever for Change.

In conclusion, the recognition received by the Preeclampsia Foundation is a potent reminder of the ongoing challenges in women’s health and the imperative for continued advocacy, research, and financial investment in this vital field. The initiative embodies hope not only for women diagnosed with hypertensive disorders but for all women worldwide, seeking better health outcomes and equitable healthcare solutions.

For further inquiries or insights on this topic, please reach out to:
Laney Poye
Director of Communications
Phone: (321) 421-6957
Email: [email protected]